EA029150B1 - Способ оценки чувствительности пациента к удалению жидкости из его сосудистой системы, замене или добавлению жидкости и соответствующий контроллер - Google Patents
Способ оценки чувствительности пациента к удалению жидкости из его сосудистой системы, замене или добавлению жидкости и соответствующий контроллер Download PDFInfo
- Publication number
- EA029150B1 EA029150B1 EA201200603A EA201200603A EA029150B1 EA 029150 B1 EA029150 B1 EA 029150B1 EA 201200603 A EA201200603 A EA 201200603A EA 201200603 A EA201200603 A EA 201200603A EA 029150 B1 EA029150 B1 EA 029150B1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- patient
- fluid
- vascular system
- volume
- blood
- Prior art date
Links
- 239000012530 fluid Substances 0.000 title claims abstract description 59
- 238000000034 method Methods 0.000 title claims abstract description 30
- 230000002792 vascular Effects 0.000 title claims abstract description 19
- 230000035945 sensitivity Effects 0.000 title claims abstract description 16
- 238000002637 fluid replacement therapy Methods 0.000 title abstract 3
- 210000004369 blood Anatomy 0.000 claims abstract description 46
- 239000008280 blood Substances 0.000 claims abstract description 46
- 238000005259 measurement Methods 0.000 claims abstract description 27
- 208000007502 anemia Diseases 0.000 claims abstract description 21
- 210000003722 extracellular fluid Anatomy 0.000 claims abstract description 18
- 230000037396 body weight Effects 0.000 claims abstract description 16
- 238000009434 installation Methods 0.000 claims description 20
- 108010054147 Hemoglobins Proteins 0.000 claims description 13
- 102000001554 Hemoglobins Human genes 0.000 claims description 13
- 238000004590 computer program Methods 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- 238000005534 hematocrit Methods 0.000 claims description 3
- 208000031648 Body Weight Changes Diseases 0.000 abstract 1
- 230000004579 body weight change Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- 230000008859 change Effects 0.000 description 16
- 238000011282 treatment Methods 0.000 description 15
- 150000001875 compounds Chemical class 0.000 description 14
- 238000000502 dialysis Methods 0.000 description 14
- 239000007788 liquid Substances 0.000 description 14
- 210000001519 tissue Anatomy 0.000 description 13
- 230000036571 hydration Effects 0.000 description 11
- 238000006703 hydration reaction Methods 0.000 description 11
- 238000004364 calculation method Methods 0.000 description 9
- 230000007423 decrease Effects 0.000 description 6
- 230000003834 intracellular effect Effects 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 102000003951 Erythropoietin Human genes 0.000 description 4
- 108090000394 Erythropoietin Proteins 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 229940105423 erythropoietin Drugs 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 206010016803 Fluid overload Diseases 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000000601 blood cell Anatomy 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- -1 for example Substances 0.000 description 2
- 208000031723 hereditary 8 angioedema Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000009747 swallowing Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010074051 C-Reactive Protein Proteins 0.000 description 1
- 102100032752 C-reactive protein Human genes 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010018092 Generalised oedema Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 208000024783 anasarca Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 238000002615 hemofiltration Methods 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000009291 secondary effect Effects 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/03—Measuring fluid pressure within the body other than blood pressure, e.g. cerebral pressure ; Measuring pressure in body tissues or organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1601—Control or regulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1601—Control or regulation
- A61M1/1603—Regulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3403—Regulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3607—Regulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3607—Regulation parameters
- A61M1/3609—Physical characteristics of the blood, e.g. haematocrit, urea
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
-
- G—PHYSICS
- G05—CONTROLLING; REGULATING
- G05B—CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
- G05B15/00—Systems controlled by a computer
- G05B15/02—Systems controlled by a computer electric
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
- A61B5/0261—Measuring blood flow using optical means, e.g. infrared light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
- A61B5/0265—Measuring blood flow using electromagnetic means, e.g. electromagnetic flowmeter
- A61B5/027—Measuring blood flow using electromagnetic means, e.g. electromagnetic flowmeter using catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
- A61B5/14557—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases specially adapted to extracorporeal circuits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
- A61M2205/058—General characteristics of the apparatus combined with other kinds of therapy with ultrasound therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3303—Using a biosensor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3306—Optical measuring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
- A61M2205/3334—Measuring or controlling the flow rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
- A61M2205/3344—Measuring or controlling pressure at the body treatment site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/005—Parameter used as control input for the apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/201—Glucose concentration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/207—Blood composition characteristics hematocrit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/65—Impedance, e.g. conductivity, capacity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Physiology (AREA)
- General Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optics & Photonics (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Automation & Control Theory (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Electromagnetism (AREA)
- External Artificial Organs (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25387809P | 2009-10-22 | 2009-10-22 | |
| EP09013356A EP2316334A1 (en) | 2009-10-22 | 2009-10-22 | A method for assessing a patient's fluid status and /or sensitivity to fluid removal, controller, and devices |
| PCT/EP2010/006433 WO2011047859A1 (en) | 2009-10-22 | 2010-10-21 | A method for assessing a patient's fluid status and/or sensitivity to fluid removal, controller, and devices |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA201200603A1 EA201200603A1 (ru) | 2012-12-28 |
| EA029150B1 true EA029150B1 (ru) | 2018-02-28 |
Family
ID=41682792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201200603A EA029150B1 (ru) | 2009-10-22 | 2010-10-21 | Способ оценки чувствительности пациента к удалению жидкости из его сосудистой системы, замене или добавлению жидкости и соответствующий контроллер |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US8827942B2 (enExample) |
| EP (3) | EP2316334A1 (enExample) |
| JP (1) | JP5716259B2 (enExample) |
| KR (1) | KR101873947B1 (enExample) |
| CN (1) | CN102596020B (enExample) |
| AU (1) | AU2010310099B2 (enExample) |
| BR (1) | BR112012009503A2 (enExample) |
| CA (1) | CA2778485C (enExample) |
| EA (1) | EA029150B1 (enExample) |
| IN (1) | IN2012DN03439A (enExample) |
| WO (1) | WO2011047859A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2316334A1 (en) * | 2009-10-22 | 2011-05-04 | Fresenius Medical Care Deutschland GmbH | A method for assessing a patient's fluid status and /or sensitivity to fluid removal, controller, and devices |
| DK2507618T3 (en) * | 2009-11-30 | 2015-07-27 | Ge Healthcare Bio Sciences Ab | Method and system for interaction analysis |
| US9750862B2 (en) * | 2011-04-29 | 2017-09-05 | Medtronic, Inc. | Adaptive system for blood fluid removal |
| CN103998072B (zh) * | 2011-09-19 | 2018-02-06 | 弗雷森纽斯医疗护理控股有限公司 | 透析患者的干重量估计 |
| DE102014104768A1 (de) * | 2014-04-03 | 2015-10-29 | B. Braun Avitum Ag | Vorrichtung und Verfahren zum Bestimmen eines Verteilungsvolumens bei einem Dialysepatienten |
| DE102014013886A1 (de) * | 2014-09-18 | 2016-03-24 | Fresenius Medical Care Deutschland Gmbh | Verfahren und Vorrichtung zur Vorhersage von einem oder mehreren für den Ausgang einer Blutbehandlung charakteristischen Parametern |
| JP6555715B2 (ja) * | 2015-08-03 | 2019-08-07 | 国立大学法人千葉大学 | リンパ浮腫モニタ装置 |
| US20210187178A1 (en) * | 2018-08-23 | 2021-06-24 | Nipro Corporation | Extracellular fluid volume calculator and method for calculating extracellular fluid volume |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050102165A1 (en) * | 2000-12-27 | 2005-05-12 | Shuzo Oshita | Biological information and blood treating device information control system, biological information and blood treating device information control device, and biological information and blood treating device information control method |
| US20090182204A1 (en) * | 2001-10-04 | 2009-07-16 | Semler Herbert J | Body composition, circulation, and vital signs monitor and method |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5280429A (en) * | 1991-04-30 | 1994-01-18 | Xitron Technologies | Method and apparatus for displaying multi-frequency bio-impedance |
| US6061590A (en) * | 1997-06-03 | 2000-05-09 | Transonic Systems, Inc. | Method and apparatus for predicting intradialytic morbid events through the monitoring of a central blood volume |
| AR019025A1 (es) | 1998-04-09 | 2001-12-26 | Roche Diagnostics Gmbh | Uso de eritropoyetina en bajas dosis para producir un preparado farmaceutico para el tratamiento de hemocromatosis, preparado farmaceutico combinadoutilizado segun dicho uso y envase farmaceutico unitario que contiene al referido preparado farmaceutico combinado |
| EP1082056B1 (en) * | 1998-06-03 | 2007-11-14 | Scott Laboratories, Inc. | Apparatus for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures |
| BR0009799B1 (pt) * | 1999-04-30 | 2009-01-13 | sistemas de controle e de hemoinfiltraÇço contÍnua. | |
| JP2001321352A (ja) | 2000-05-16 | 2001-11-20 | Sekisui Chem Co Ltd | 電気特性測定装置 |
| EP1205144B1 (en) * | 2000-11-06 | 2002-10-02 | Fresenius Medical Care Deutschland GmbH | A method and a device for determining the dry weight of a patient with kidney failure |
| ATE363859T1 (de) | 2001-12-12 | 2007-06-15 | Fresenius Medical Care De Gmbh | Bestimmung des hydratationszustandes eines patienten |
| JP4129866B2 (ja) | 2002-07-18 | 2008-08-06 | 日機装株式会社 | 血液処理装置 |
| FR2849736A1 (fr) * | 2003-01-02 | 2004-07-09 | Thomson Licensing Sa | Dispositif et procede d'acquisition de fichiers par accumulation de points et produits associes |
| CN1960672B (zh) | 2004-06-29 | 2010-05-12 | 弗雷森纽斯医疗护理德国有限责任公司 | 确定病人水合和/或营养状况的方法和装置 |
| JP4726045B2 (ja) | 2005-04-08 | 2011-07-20 | 日機装株式会社 | 血液透析装置 |
| CN101291617B (zh) * | 2005-09-15 | 2010-08-18 | 马蒂尔仪器有限公司 | 用于确定血管中的流体的设备 |
| JP4822258B2 (ja) * | 2005-11-11 | 2011-11-24 | 日機装株式会社 | 血液透析装置 |
| US7539533B2 (en) * | 2006-05-16 | 2009-05-26 | Bao Tran | Mesh network monitoring appliance |
| US20080013747A1 (en) * | 2006-06-30 | 2008-01-17 | Bao Tran | Digital stethoscope and monitoring instrument |
| EP2316334A1 (en) * | 2009-10-22 | 2011-05-04 | Fresenius Medical Care Deutschland GmbH | A method for assessing a patient's fluid status and /or sensitivity to fluid removal, controller, and devices |
-
2009
- 2009-10-22 EP EP09013356A patent/EP2316334A1/en not_active Withdrawn
-
2010
- 2010-10-21 KR KR1020127010247A patent/KR101873947B1/ko not_active Expired - Fee Related
- 2010-10-21 EA EA201200603A patent/EA029150B1/ru not_active IP Right Cessation
- 2010-10-21 US US13/503,139 patent/US8827942B2/en not_active Expired - Fee Related
- 2010-10-21 JP JP2012534578A patent/JP5716259B2/ja not_active Expired - Fee Related
- 2010-10-21 AU AU2010310099A patent/AU2010310099B2/en not_active Ceased
- 2010-10-21 BR BR112012009503A patent/BR112012009503A2/pt not_active Application Discontinuation
- 2010-10-21 CN CN201080047456.3A patent/CN102596020B/zh active Active
- 2010-10-21 CA CA2778485A patent/CA2778485C/en active Active
- 2010-10-21 IN IN3439DEN2012 patent/IN2012DN03439A/en unknown
- 2010-10-21 WO PCT/EP2010/006433 patent/WO2011047859A1/en not_active Ceased
- 2010-10-21 EP EP19165767.5A patent/EP3545831A1/en not_active Withdrawn
- 2010-10-21 EP EP10770729.1A patent/EP2490588B1/en not_active Not-in-force
-
2014
- 2014-08-18 US US14/461,902 patent/US9486567B2/en active Active
-
2016
- 2016-06-10 US US15/179,499 patent/US10737009B2/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050102165A1 (en) * | 2000-12-27 | 2005-05-12 | Shuzo Oshita | Biological information and blood treating device information control system, biological information and blood treating device information control device, and biological information and blood treating device information control method |
| US20090182204A1 (en) * | 2001-10-04 | 2009-07-16 | Semler Herbert J | Body composition, circulation, and vital signs monitor and method |
Non-Patent Citations (4)
| Title |
|---|
| ANTONIO PICCOLI: "Bioelectric impedance vector distribution in peritoneal dialysis patients with different hydration status", KIDNEY INTERNATIONAL, NATURE PUBLISHING GROUP, LONDON, GB, vol. 65, 1 January 2004 (2004-01-01), pages 1060-1063, XP007912084, ISSN: 0085-2538, the whole document * |
| PETER WABEL ET AL.: "Importance of Whole-Body Bioimpedance Spectroscopy for the Management of Fluid Balance", BLOOD PURIFICATION, vol. 27, 23 January 2009 (2009-01-23), pages 75-80, XP007912086, ISSN: 0253-5068, [retrieved on 2009-01-23], the whole document * |
| SHUTA ISHIBE AND ALDO J. PEIXOTO: "Methods of Assessment of Volume Status and Intercompartmental Fluid Shifts in Hemodialysis Patients: Implications in Clinical Practice", SEMINARS IN DIALYSIS, WAVERLY PRESS, BALTIMORE, MD, US, vol. 17, no. 1, 1 January 2004 (2004-01-01), pages 37-43, XP007912112, ISSN: 0894-0959, the whole document * |
| VOLKER WIZEMANN ET AL.: "The mortality risk of overhydration in haemodialysis patients", NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIVERSITY PRESS, GB, 1 January 2009 (2009-01-01), pages 1-6, XP007912087, ISSN: 0931-0509, the whole document * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20160243297A9 (en) | 2016-08-25 |
| BR112012009503A2 (pt) | 2017-10-24 |
| US9486567B2 (en) | 2016-11-08 |
| KR101873947B1 (ko) | 2018-07-03 |
| WO2011047859A8 (en) | 2011-06-16 |
| CN102596020B (zh) | 2016-08-03 |
| EP2490588B1 (en) | 2019-04-03 |
| US20120238935A1 (en) | 2012-09-20 |
| EP2490588A1 (en) | 2012-08-29 |
| CN102596020A (zh) | 2012-07-18 |
| CA2778485C (en) | 2020-12-15 |
| EA201200603A1 (ru) | 2012-12-28 |
| CA2778485A1 (en) | 2011-04-28 |
| AU2010310099A1 (en) | 2012-05-17 |
| US10737009B2 (en) | 2020-08-11 |
| US20150335805A1 (en) | 2015-11-26 |
| WO2011047859A1 (en) | 2011-04-28 |
| KR20120102607A (ko) | 2012-09-18 |
| JP5716259B2 (ja) | 2015-05-13 |
| AU2010310099B2 (en) | 2015-12-10 |
| EP2316334A1 (en) | 2011-05-04 |
| EP3545831A1 (en) | 2019-10-02 |
| JP2013508042A (ja) | 2013-03-07 |
| US8827942B2 (en) | 2014-09-09 |
| US20160361480A1 (en) | 2016-12-15 |
| IN2012DN03439A (enExample) | 2015-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6208193B2 (ja) | ろ過率の制御方法を行うコントローラ、装置及びデバイス | |
| JP5716259B2 (ja) | 患者の体液状態及び／又は体液除去に対する感度を評価する方法、コントローラ、及び装置 | |
| US10551370B2 (en) | Method and apparatus for evaluating values representing a mass or a concentration of a substance present within the body of a patient | |
| Wang | Impact of hydration and nutrition status on the Watson formula in peritoneal dialysis patients | |
| Kraut et al. | The use and interpretation of serum bicarbonate concentration in dialysis patients. | |
| Brown | Iranian Journal of | |
| Davidson et al. | Development of indices for determining extracellular fluid sodium and water status in acute diabetic ketoacidosis: possible tools for clinical audit | |
| HK1170968A (en) | Method and apparatus for evaluating values representing a mass or a concentration of a substance present within the body of a patient | |
| HK1170968B (en) | Method and apparatus for evaluating values representing a mass or a concentration of a substance present within the body of a patient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |